Boston Scientific (BSX)
104.50
-0.01 (-0.01%)
NYSE · Last Trade: May 30th, 1:14 AM EDT
Detailed Quote
Previous Close | 104.51 |
---|---|
Open | 104.50 |
Bid | 103.57 |
Ask | 105.34 |
Day's Range | 103.87 - 105.00 |
52 Week Range | 71.88 - 107.17 |
Volume | 7,129,644 |
Market Cap | 148.79B |
PE Ratio (TTM) | 76.28 |
EPS (TTM) | 1.4 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 6,532,399 |
Chart
About Boston Scientific (BSX)
Boston Scientific is a global medical technology company that specializes in the development, manufacturing, and marketing of a wide range of medical devices and solutions. The company focuses on providing innovative therapies for various medical conditions, including those affecting the cardiovascular, urology, and gastrointestinal systems, among others. Boston Scientific is committed to advancing patient care through its pioneering technologies, which are designed to improve outcomes and enhance the quality of life for patients around the world. Their product offerings include devices for minimally invasive procedures, enabling healthcare professionals to deliver high-quality care efficiently and effectively. Read More
News & Press Releases

Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted.
Via Investor's Business Daily · May 29, 2025

Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to meet 2025 sales.
Via Benzinga · May 28, 2025

The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals in new regions.
Via Stocktwits · May 28, 2025

The company said the regulatory path forward for one of its key systems is too murky to pursue.
Via Investor's Business Daily · May 28, 2025
Boston Scientific Corp (NYSE:BSX) shows strong growth fundamentals and a bullish technical setup, making it a compelling candidate for growth investors.
Via Chartmill · May 26, 2025
Let’s dig into the relative performance of Boston Scientific (NYSE:BSX) and its peers as we unravel the now-completed Q1 medical devices & supplies - diversified earnings season.
Via StockStory · May 25, 2025
Via Benzinga · May 20, 2025
Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.
Via Chartmill · May 20, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) meets Minervini’s Trend Template with strong technicals and high growth fundamentals, making it a candidate for momentum investors.
Via Chartmill · May 19, 2025
Via Benzinga · May 16, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) shows strong technicals and a high-quality setup, making it a breakout candidate. The stock has outperformed peers and exhibits bullish patterns with clear support and resistance levels.
Via Chartmill · May 13, 2025
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence.
With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
Via StockStory · May 13, 2025
A fundamental and technical analysis of (NYSE:BSX): Should you consider BOSTON SCIENTIFIC CORP (NYSE:BSX) for high growth investing?
Via Chartmill · May 9, 2025
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Via StockStory · May 5, 2025
Via Benzinga · May 1, 2025
See these three stocks that beat on earnings in Q1 and raised their guidance for the rest of 2025. These stocks are signaling strength amid tough conditions.
Via MarketBeat · April 29, 2025
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via StockStory · April 29, 2025
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC)
will be reporting earnings tomorrow before market hours. Here’s what to expect.
Via StockStory · April 29, 2025
Dental technology company Align Technology (NASDAQ:ALGN)
will be reporting results tomorrow after market close. Here’s what you need to know.
Via StockStory · April 29, 2025
Medical tech company CONMED (NYSE:CNMD)
will be reporting earnings tomorrow after market close. Here’s what you need to know.
Via StockStory · April 29, 2025
A fundamental and technical analysis of (NYSE:BSX): Delving into BOSTON SCIENTIFIC CORP (NYSE:BSX)'s high Growth Prospects.
Via Chartmill · April 28, 2025
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q1 CY2025, with sales up 20.9% year on year to $4.66 billion. The company expects next quarter’s revenue to be around $4.88 billion, close to analysts’ estimates. Its non-GAAP profit of $0.75 per share was 11.5% above analysts’ consensus estimates.
Via StockStory · April 24, 2025
Via Benzinga · April 24, 2025
Shares of medical device company Boston Scientific (NYSE:BSX)
jumped 8.5% in the pre-market session after the company reported first quarter 2025 results that beat analysts' sales and EPS expectations. Organic sales growth topped the company's own forecast and was led by a 25.6% surge in its Cardiovascular segment, a signal that demand in its largest business is accelerating.
Looking ahead, its revenue guidance for next quarter exceeded Wall Street's estimates. Overall, we think this was a decent quarter with some key metrics above expectations.
Via StockStory · April 23, 2025